Biotech Values

[DewDiligence]

2Q22 worldwide Botox sales=$1.255B, +9% QoQ*, +18% YoY†:

https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-second-quarter-2022-financial-results

• US therapeutic: $557M (+11% QoQ*, +14% YoY)
• US cosmetic: $449M 413M (+9% QoQ*, +22% YoY)
--
US total: $1.006B (55% therapeutic; 45% cosmetic) was 73% of worldwide total


• Ex-US therapeutic: $121M (+6% QoQ*, +16% YoY†)
• Ex-US cosmetic: $246M 228M (+8% QoQ*, +19% YoY†)
--
Ex-US total: $367M (33% therapeutic; 67% cosmetic) was 27% of worldwide total


*Botulinum-toxin sales are seasonally stronger during the second and fourth calendar quarters than the first and third calendar quarters.

†Ex-US growth measured in local currency.